GLOBAL
INTELLIGENCE REPORT

GIB · GLOBEINTELREPORT.COM

Support GIBSite updatedOct 16, 2026•••
Full GIB infographic explaining the research platform
Latest headlines
GIB / Global Intelligence Brief

Autism and cancer evidence scan finds no qualifying causal breakthrough

AI-generated editorial graphic for Autism and cancer evidence scan finds no qualifying causal breakthrough
Preparing article image…

No new replicated autism-causation finding or cancer result meeting GIB's cure standard was identified. Genetic influences, prenatal or perinatal exposures, environmental associations, surveillance changes, proposed mechanisms, and unsupported claims remain separate evidence categories. High-quality evidence does not support vaccines as a cause of autism, while legitimate vaccine-safety surveillance remains necessary.

82% ConfidenceThis is a bounded evidence scan rather than proof that no unpublished or inaccessible research exists.
01

Central finding

No new replicated causal autism finding or cancer result meeting GIB's cure standard was identified. Genetic findings, prenatal and perinatal exposures, environmental associations, surveillance changes, proposed mechanisms, and unsupported claims remain separate evidence categories.

  • No qualifying replicated autism-causation result was identified.
  • No qualifying cancer cure was verified.
02

Evidence and limits

This is a bounded evidence scan rather than proof that no unpublished or inaccessible research exists.

  • Evidence searches are constrained by publication timing and access.
03

Why it matters

Patients and families are harmed when preliminary associations or limited treatment results are promoted as established causes or cures.

04

What changed

No qualifying causal or cure-level breakthrough was verified in the reporting window.

05

What comes next

Replicated causal studies, preregistered trials, FDA actions, and mature survival or functional-outcome data.

06

What changed

No qualifying causal autism finding or cure-level cancer breakthrough was verified in the reporting window.

U.S. strategic assessment

High interest

Patients and families are harmed when preliminary associations or limited treatment results are promoted as established causes or cures.

Objectives

  • Protect U.S. security, economic resilience, and citizens using measurable, lawful action.

Strategy

  • Use primary records, allied coordination, market evidence, and independent verification to distinguish action from rhetoric.

Outcomes

  • No result crossed the publication threshold during the window.

Risks

  • Evidence searches are constrained by publication timing and access.

Sources

01
FDA — drug approvals and safety

Primary record

Primary ↗